Eva K. Billerbeck, Ph.D.

Our research is focused on understanding the immune system of the liver in health and disease. Inflammatory liver diseases such as chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection are leading causes for the development of liver cirrhosis and hepatocellular carcinoma (HCC).

As a major metabolic organ of the body the liver is prone towards immune tolerance as it is constantly exposed to gut-derived blood rich in bacterial and dietary antigens. The liver is also enriched in various tissue-resident innate, innate-like and adaptive immune cell populations, such as Kupffer cells, natural killer (NK) cells, invariant natural killer T (iNKT) cells, mucosal-associated invariant T (MAIT) cells and CD4+ and CD8+ T cell subsets. This unique immunological microenvironment may play an essential role in controlling the outcome of a hepatic virus infection as well as the development of immunopathology and liver disease progression during inflammatory liver disease.

It is our aim to understand how different immune cells subsets and their interactions in this tissue-specific environment contribute to the opposing outcomes of: 1) viral clearance and protection from secondary infection versus establishment of chronic viral infection and 2) tissue protection and repair versus development of immunopathology and progressive liver disease.

Our long-term goal is to translate basic findings from mouse models of viral hepatitis to the human liver and to develop new strategies for vaccine design or immuno-therapeutic treatment of virus-associated liver disease.

Lopez-Scarim J, Mendoza D, Nambiar SM, Billerbeck E. CD4+ T cell help during early acute hepacivirus infection is critical for viral clearance and the generation of a liver-homing CD103+CD49a+ effector CD8+ T cell subset. PLoS Pathog. 2024 Oct 11;20(10):e1012615. doi: 10.1371/journal.ppat.1012615. eCollection 2024 Oct.

Brown AJ, Won JJ, Wolfisberg R, Fahnøe U, Catanzaro N, West A, Moreira FR, Nogueira Batista M, Ferris MT, Linnertz CL, Leist SR, Nguyen C, De la Cruz G, Midkiff BR, Xia Y, Evangelista MD, Montgomery SA, Billerbeck E, Bukh J, Scheel TKH, Rice CM, Sheahan TP. Host genetic variation guides hepacivirus clearance, chronicity and liver fibrosis in mice. Hepatology. 2024 Jan 1;79(1):183-197. doi: 10.1097/HEP.0000000000000547. Epub 2023 Aug 7.

Lopez-Scarim J, Nambiar SM, Billerbeck E. Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment. Vaccines (Basel). 2023 Mar 17;11(3):681. doi: 10.3390/vaccines11030681.

Raus S, Lopez-Scarim J, Luthy J and Billerbeck E. Hepatic iNKT cells produce type 2 cytokines and restrain antiviral T cells during acute hepacivirus infection. Front Immunol. 2022 Sept 8; 13:953151. doi: 10.3389/fimmu.2022.953151

Wu X, Dao Thi VL, Huang Y, Billerbeck E, Saha D, Hoffmann HH, Wang Y, Silva LAV, Sarbanes S, Sun T, Andrus L, Yu Y, Quirk C, Li M, MacDonald MR, Schneider WM, An X, Rosenberg BR, Rice CM. Intrinsic immunity shapes viral resistance of stem cells.
Cell. 2018 Jan 25;172(3):423-438.e25. doi: 10.1016/j.cell.2017.11.018.

Billerbeck E, Wolfisberg R, Fahnoe U, Xiao WJ, Quirk C, Luna JM, Cullen JM, Hartlage AS, Chiriboga C, Ghoshal K, Lipkin IW, Bukh J, Scheel TKH, Kapoor A, Rice CM
Mouse models of acute and chronic hepacivirus infection. Science. 2017 Jul 14;357(6347):204-208.

Billerbeck E*, Mommersteeg MC*, Shlomai A, Xiao JW, Andrus L, Bhatta A, Vercauteren K, Michaillidis E, Dorner M, Krishnan A, Charlton MR, Chiriboga L, Rice CM, de Jong YP. Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. J Hepatol. 2016 Aug;65(2):334-43.
* equal contribution

Billerbeck E*, Kang YH*, Walker L, Lockstone H, Grafmueller S, Fleming V, Flint J, Willberg CB, Bengsch B, Seigel B, Ramamurthy N, Zitzmann N, Barnes EJ, Thevanayagam J, Bhagwanani A, Leslie A, Oo YH, Kollnberger S, Bowness P, Drognitz O, Adams DH, Blum HE, Thimme R, Klenerman P. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3006-11
* equal contribution